LONDON--(BUSINESS WIRE)--Technavio market research analysts forecast the global patient warming devices market to grow at a CAGR of more than 7% during the forecast period, according to their latest report.
The market study covers the present scenario and growth prospects of the global patient warming devices market for 2017-2021. The report also lists systems, and surface warming devices and accessories as the two major product segments. Systems are a one-time-investment while surface warming devices are reusable or disposable devices including mattress and blankets and accessories such as IV tubes, injection ports, and batteries. The high cost of disposable surface warmers and accessories is expected to have a positive impact on the growth of the market.
According to Srinivas Sashidar, a lead analyst at Technavio for patient monitoring devices “The global patient warming devices market is expected to grow at a moderate pace during the forecast period owing to an increase in the incidence of trauma incidents, diabetes, and thyroid disorders along with rising drug and alcohol consumption. The treatment of these conditions involves the use of these devices to prevent mortality from complications like hypothermia and hemorrhage.”
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio analysts highlight the following three market drivers that are contributing to the growth of the global patient warming devices market:
- Increasing prevalence of hypothermia
- Increase in blood transfusion procedures
- Government initiatives for thyroid and diabetes conditions
Increasing prevalence of hypothermia
Hypothermia is a potentially fatal, emergency situation that presents with symptoms such as confusion, loss of fine motor skills, and amnesia. Without adequate rewarming, continued heat loss can result in hypotension, impaired respiration, cardiac arrhythmia, and death. The common causes of hypothermia include medical conditions, exposure to extreme cold, age, and medical complications in physical trauma and surgical patients. Hypothermia is also a common occurrence in unwarmed surgical patients under anesthesia which can result in major complications. The anesthetic agent reduces the patient's metabolism and thermoregulatory system which will increase the prevalence of hypothermia.
Increase in blood transfusion procedures
Blood transfusion is a common life-saving procedure during emergency treatments and surgeries as well as in the case of loss of blood due to severe injury. In 2013, the CDC estimated that five million patients undergo blood transfusion annually in the US. During blood transfusion, the blood needs to be warmed using a fluid or blood warmer to avoid complications. Blood and fluid warming devices are used surgeries to prevent hypothermia.
Government initiatives for thyroid and diabetes conditions
Another driver influencing the growth of the patient warming devices market is the increasing incidence of thyroid and diabetes. Hypothermia is a sign of hypoglycemia as low blood sugar levels can damage the nerves that help regulate the body temperature. Similarly, hypothyroidism can impair the body’s ability to thermoregulate and affects the core body temperature. In 2016, 29 million US adults were estimated to have diabetes.
“Due to the rising prevalence of diabetes, CDC launched programs and initiatives like Diabetes State and Local Program, National Diabetes Prevention Program, and National Diabetes Education Program to reduce the incidence of diabetes using a combination of scientifically proven, cost-effective, and scalable intervention and prevention strategies,” says Srinivas.
Browse Other Reports:
- Global Echocardiography (ECG) Devices Market 2017-2021
- Global Intraoperative Neuromonitoring Market 2017-2021
- Global Pulse Oximetry Market 2017-2021
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like in-vitro diagnostics, vaccines, and urology devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently. About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading-edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
